What is the address of MEDIDERM?

The registered office of MEDIDERM is located at Quai du Halage 10, 4681 Oupeye.

Is MEDIDERM still active?

Yes. According to the CBE (30 October 2026) MEDIDERM is active, legal situation “Normale toestand”, started on 25 June 1987.

Is MEDIDERM registered on Peppol?

No, MEDIDERM is currently not registered on the Peppol network.

What is the enterprise number of MEDIDERM?

The enterprise number of MEDIDERM is BE0431598728.

When was MEDIDERM founded?

MEDIDERM was founded on 25 June 1987.

Who are the directors of MEDIDERM?

According to the 2025 annual accounts, the directors of MEDIDERM are: Albert LEGRAIN.

Is MEDIDERM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 June 1987; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDIDERM make in 2025?

MEDIDERM posted a profit after taxes of € 54,365 in financial year 2025.

What is the revenue of MEDIDERM?

As a small company, MEDIDERM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 75,957.

MEDIDERM (Private Limited) - Oupeye - BE0431598728

Dossier MEDIDERM, printed on 30 October 2026 from databakkes.be/en/0431598728/mediderm. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

MEDIDERM from Oupeye, company number BE0431598728, closed financial year 2025 with a result of € 54,365 after tax. For that financial year MEDIDERM recorded a gross margin of € 75,957 and equity of € 37,649. Compared with financial year 2024, the result moved from € 30,915 to € 54,365. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Growing

€ 37,649

▲ 83% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 54,365

▲ 76% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 15,964

▼ 4% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 37,341 paid out

69 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,110

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 32,717

▲ 29% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 43,058 Gross margin 2022: € 43,058 First fiscal year in the series	€ 31,584 Gross margin 2023: € 31,584 ▼ 27% vs 2022 (€ 43,058) Unfavourable step	€ 43,860 Gross margin 2024: € 43,860 ▲ 39% vs 2023 (€ 31,584) Favourable step	€ 75,957 Gross margin 2025: € 75,957 ▲ 73% vs 2024 (€ 43,860) Favourable step	▲ 73%
Profit after taxes	€ 30,252 Profit after taxes 2022: € 30,252 First fiscal year in the series	€ 21,436 Profit after taxes 2023: € 21,436 ▼ 29% vs 2022 (€ 30,252) Unfavourable step	€ 30,915 Profit after taxes 2024: € 30,915 ▲ 44% vs 2023 (€ 21,436) Favourable step	€ 54,365 Profit after taxes 2025: € 54,365 ▲ 76% vs 2024 (€ 30,915) Favourable step	▲ 76%
Equity	€ 20,625 Equity 2022: € 20,625 First fiscal year in the series	€ 20,625 Equity 2023: € 20,625 Unchanged (€ 20,625) Unchanged	€ 20,625 Equity 2024: € 20,625 Unchanged (€ 20,625) Unchanged	€ 37,649 Equity 2025: € 37,649 ▲ 83% vs 2024 (€ 20,625) Favourable step	▲ 83%
Total debts	€ 45,562 Total debts 2022: € 45,562 First fiscal year in the series	€ 31,595 Total debts 2023: € 31,595 ▼ 31% vs 2022 (€ 45,562) Favourable step	€ 47,307 Total debts 2024: € 47,307 ▲ 50% vs 2023 (€ 31,595) Unfavourable step	€ 63,365 Total debts 2025: € 63,365 ▲ 34% vs 2024 (€ 47,307) Unfavourable step	▲ 34%
Cash	€ 12,474 Cash 2022: € 12,474 First fiscal year in the series	€ 10,073 Cash 2023: € 10,073 ▼ 19% vs 2022 (€ 12,474) Unfavourable step	€ 16,677 Cash 2024: € 16,677 ▲ 66% vs 2023 (€ 10,073) Favourable step	€ 15,964 Cash 2025: € 15,964 ▼ 4% vs 2024 (€ 16,677) Unfavourable step	▼ 4%
Retained profit	€ 1,875 Retained profit 2022: € 1,875 First fiscal year in the series	€ 1,875 Retained profit 2023: € 1,875 Unchanged (€ 1,875) Unchanged	€ 1,875 Retained profit 2024: € 1,875 Unchanged (€ 1,875) Unchanged	€ 18,899 Retained profit 2025: € 18,899 ▲ € 17,024 vs 2024 (€ 1,875) Favourable step	▲ € 17,024
Dividend	€ 30,252 Dividend 2022: € 30,252 First fiscal year in the series	€ 21,436 Dividend 2023: € 21,436 ▼ 29% vs 2022 (€ 30,252) Unchanged	€ 30,915 Dividend 2024: € 30,915 ▲ 44% vs 2023 (€ 21,436) Unchanged	€ 37,341 Dividend 2025: € 37,341 ▲ 21% vs 2024 (€ 30,915) Unchanged	▲ 21%
Balance sheet total	€ 66,187 Balance sheet total 2022: € 66,187 First fiscal year in the series	€ 52,220 Balance sheet total 2023: € 52,220 ▼ 21% vs 2022 (€ 66,187) Unchanged	€ 67,932 Balance sheet total 2024: € 67,932 ▲ 30% vs 2023 (€ 52,220) Unchanged	€ 101,014 Balance sheet total 2025: € 101,014 ▲ 49% vs 2024 (€ 67,932) Unchanged	▲ 49%

Key figures of MEDIDERM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDIDERM?

What happened at MEDIDERM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 54,365 (▲ 76% vs 2024). filed late Source: NBB ↗
Jun 25, 1987 Start of the company according to the CBE. KBO

In short

From € 30,252 profit in 2022 to € 54,365 profit in 2025.

Paid € 52,235 in corporate taxes since 2022.

Best year ever: 2025, with € 54,365 profit.

Paid out € 119,945 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Albert LEGRAIN

MEDIDERM

Behind MEDIDERM is Albert LEGRAIN.

Directors

According to the 2025 annual accounts

Albert LEGRAIN

Managing director

Establishments

Establishment units

Physical locations of this company

Registered office

Quai du Halage 10

4681 Oupeye

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0431.598.728
VAT number: BE 0431.598.728
Registered office: Quai du Halage 10, 4681 Oupeye
Names & denominations: MEDIDERM
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 25 June 1987
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗